Clinical Trials Logo

Clinical Trial Summary

The goal of this study is to identify genetic alterations resulting in the development of arteriovenous malformation (AVM) in the central nervous system.


Clinical Trial Description

The study will include AVM patients and members of their nuclear family. All patients will donate a sample of saliva (5 mL) or blood (10 mL). Basic demographic and clinical parameters will be collected, including ethnicity, age at first presentation, symptoms at presentation, history of subsequent symptoms, treatment history, Spetzler-Martin AVM grade, medication history, and other pertinent medical information. In patients undergoing AVM resection, a small sample of the AVM will be collected for concurrent genomic analysis. Family members will donate saliva (5mL) and document their relationship to the patient (i.e., parent, sibling, child, etcl). Nucleic acids will be isolated from the saliva/blood samples, and genetic sequencing will be carried out. When a surgical sample of the AVM is available, nucleic acids will be obtained and transcriptome profiling will be performed. Identification of genetic alterations common to patients with AVM and not present in samples from parents and siblings will greatly aid in identification of pathways associated with AVM formation. Candidate sequences will be chosen by differential expression (p<0.05) and fold-changes. Once identified, mechanisms for the rapid detection of marker sequences will be developed and their predictive value tested in future collections. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02445430
Study type Observational
Source St. Joseph's Hospital and Medical Center, Phoenix
Contact
Status Active, not recruiting
Phase
Start date May 2015
Completion date June 30, 2023

See also
  Status Clinical Trial Phase
Recruiting NCT02552459 - Effect of Dexmedetomidine Combined With Sufentanil for Postoperative Intravenous Analgesia in Neurosurgery Phase 4
Completed NCT00603694 - Hippocampal Radiation Exposure and Memory N/A
Completed NCT00389935 - Thalidomide Reduces Arteriovenous Malformation Related Gastrointestinal Bleeding Phase 2
Recruiting NCT02625389 - Evaluation of Lipiodol® Ultra Fluid in Association With Surgical Glues During Vascular Embolization. Phase 4
Completed NCT00972790 - Scalp Nerve Blocks for Post-Craniotomy Pain N/A
Completed NCT00001364 - Evaluation and Treatment of Patients Spinal Blood Vessel Abnormalities N/A
Recruiting NCT02496013 - Clinical Translation of a Novel Albumin-Binding PET Radiotracer 68Ga-NEB Phase 1
Completed NCT03269734 - Evaluation of the Accuracy of the Vessel Navigator Tool for Catheterization of Supra-aortic Vessels - ARCHIBALD